On July 10, 2025, JMP Securities, a reputable financial services firm, initiated coverage on Performant Healthcare (PHLT, Financial) with a "Market Outperform" rating. The initiation of coverage by analyst Nico Frelick has set a positive outlook for the stock.
The analyst has announced a price target of $8.00 USD for Performant Healthcare (PHLT, Financial). This price target represents the potential valuation the analyst believes the stock could reach in the future based on their analysis. The prior price target for Performant Healthcare was not available, as this marks the first initiation of coverage by JMP Securities.
The current action indicates a vote of confidence in Performant Healthcare's market position and future growth potential. Investors and stakeholders may find this newly released rating and price target from JMP Securities helpful in making informed decisions regarding Performant Healthcare (PHLT, Financial).
As always, investors are encouraged to conduct their own research or consult with their financial advisors before making any investment decisions. Stay tuned for further updates on Performant Healthcare (PHLT, Financial) as new developments arise.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 3 analysts, the average target price for Performant Healthcare Inc (PHLT, Financial) is $7.00 with a high estimate of $8.00 and a low estimate of $6.00. The average target implies an upside of 63.55% from the current price of $4.28. More detailed estimate data can be found on the Performant Healthcare Inc (PHLT) Forecast page.
Based on the consensus recommendation from 3 brokerage firms, Performant Healthcare Inc's (PHLT, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
